Facilitated By

San Antonio Medical Foundation

Advanced Development of a Multivalent Filovirus (Ebola/Marburg) Hemorrhagic Fever Vaccine

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Carrion, Ricardo
Collaborating Institutions
Janssen Pharmaceuticals Inc.
Funded by
National Institutes of Health
Research Start Date
Status
Active

The major goal is to develop a safe and effective Ebola/Marburg combination vaccine based on recombinant adenoviral vectors to induce protective immunity to these highly pathogenic viral agents.

Collaborative Project
Drug Discovery
Infectious Disease